Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
GeminiBio is a private, commercial-stage life science tools and bioprocess supplier that provides critical raw materials used in biopharmaceutical, cell therapy, and gene therapy research, development, and manufacturing. Founded in 1985 and based in West Sacramento, California, the company sells human AB serum, fetal bovine serum, custom media, buffers, high-purity water, and other process liquids used from research through commercial production. GeminiBio operates cGMP manufacturing facilities and positions itself as a workflow partner for customers developing advanced therapies, including cell therapy, AAV, mRNA, and monoclonal antibody products. The company is backed by healthcare private equity firm BelHealth Investment Partners and has expanded both its manufacturing footprint and product portfolio in recent years. GeminiBio is not a therapeutic drug developer; rather, it is a commercial supplier enabling biomanufacturing and cell culture workflows.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Gemini Biosystems.